RFK Jr.'s new vaccine advisers to discuss preservative wrongly linked to autism
A key vaccine advisory panel handpicked by Health and Human Services Secretary Robert F. Kennedy Jr. is set to vote on a vaccine ingredient wrongly linked to autism as part of its scaled-down two-day meeting next week.
It's the first meeting of the Advisory Committee on Immunization Practices (ACIP) since Kennedy fired all 17 members and appointed eight new panelists, several of whom are vocal vaccine critics.
The draft agenda for next week's ACIP meeting revisits issues that scientists and public health experts have long considered to be settled, including the use of the measles vaccine in children under 5 years old.
ACIP is an influential panel that recommends which vaccines go on the childhood and adult schedules after reviewing safety data. If ACIP endorses a vaccine, insurers must cover it.
The committee will also vote on recommendations regarding 'thimerosal containing' influenza vaccines.
Kennedy has long advocated for banning thimerosal, a preservative that was widely used for decades in a number of biological and drug products, including many vaccines. In his 2014 book, Kennedy said thimerosal was 'toxic to brain tissue' and likely caused autism.
Thimerosal, a compound that contains mercury, is used as a preservative to prevent harmful bacteria in multidose vials of vaccines. The compound has been largely phased out as manufacturers have shifted toward single-use vials that contain little or no thimerosal, according to the Centers for Disease Control and Prevention (CDC).
Thimerosal was largely removed from pediatric vaccines by 2001, amid concerns that it could be linked to autism in children. But numerous studies have disproved such a link.
According to the CDC, 'a robust body of peer-reviewed scientific studies conducted in the U.S. and other countries support the safety of thimerosal-containing vaccines.'
'Even after thimerosal was removed from almost all childhood vaccines, autism rates continued to increase, which is the opposite of what would be expected if thimerosal caused autism,' CDC says on its website.
Thimerosal is currently used in three flu vaccines for adults sold by Sanofi and CSL Seqirus, according to the Food and Drug Administration.
It's unclear yet what the panel will discuss regarding the measles, mumps, rubella and varicella vaccines (MMRV).
The current CDC childhood vaccine schedule recommends two doses for children, with the first dose at age 12-15 months and the second at age 4-6 years. CDC suggests that the MMR vaccine be given rather than MMRV for the first dose, but both shots have been on the schedule for decades.
The current agenda is pared down from what was previously on the schedule. The panel is no longer scheduled to vote on recommendations related to COVID-19 vaccines, as well as HPV and meningococcal vaccines.
Last month, Kennedy changed CDC's COVID-19 vaccine recommendation without the panel voting on it.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
2 hours ago
New CDC advisers will skip some expected topics and explore a target of antivaccine activists
U.S. Health Secretary Robert F. Kennedy Jr.'s new vaccine advisers meet next week, but their agenda suggests they'll skip some expected topics — including a vote on COVID-19 shots — while taking up a longtime target of anti-vaccine groups. The Advisory Committee on Immunization Practices makes recommendations on how to use the nation's vaccines, setting a schedule for children's vaccines as well as advice for adult shots. Last week, Kennedy abruptly dismissed the existing 17-member expert panel and handpicked eight replacements, including several anti-vaccine voices. The agenda for the new committee's first meeting, posted Wednesday, shows it will be shorter than expected. Discussion of COVID-19 shots will open the session, but the agenda lists no vote on that. Instead, the committee will vote on fall flu vaccinations, on RSV vaccinations for pregnant women and children and on the use of a preservative named thimerosal that's in a subset of flu shots. It's not clear who wrote the agenda. No committee chairperson has been named and the U.S. Department of Health and Human Services did not comment. Missing from the agenda are some heavily researched vaccine policy proposals the advisers were supposed to consider this month, including shots against HPV and meningococcal bacteria, said Dr. Susan Kressly, president of the American Academy of Pediatrics. Instead, the committee is talking about subjects 'which are settled science,' she said. 'Every American should be asking themselves how and why did we get here, where leaders are promoting their own agenda instead of protecting our people and our communities,' she said. She worried it's "part of a purposeful agenda to insert dangerous and harmful and unnecessary fear regarding vaccines into the process.' The committee makes recommendations on how vaccines that have been approved by the Food and Drug Administration should be used. The recommendations traditionally go to the Centers for Disease Control and Prevention director. Historically, nearly all are accepted and then used by insurance companies in deciding what vaccines to cover. But the CDC has no director and the committee's recommendations have been going to Kennedy. Thimerosal was added to certain vaccines in the early 20th century to make them safer and more accessible by preventing bacterial contamination in multi-dose vials. It's a tiny amount, but because it's a form of mercury, it began raising questions in the 1990s. Kennedy — a leading voice in an antivaccine movement before he became President Donald Trump's health secretary — has long held there was a tie between thimerosal and autism, and also accused the government of hiding the danger. Study after study has found no evidence that thimerosal causes autism. But since 2001, all vaccines manufactured for the U.S. market and routinely recommended for children 6 years or younger have contained no thimerosal or only trace amounts, with the exception of inactivated influenza vaccine. Thimerosal now only appears in multidose flu shot vials, not the single-shot packaging of most of today's flu shots. Targeting thimerosal would likely force manufacturers to switch to single-dose vials, which would make the shots 'more expensive, less available and more feared,' said Paul Offit, a vaccine expert at Children's Hospital of Philadelphia. Last week, 30 organizations called on insurers to continue paying for COVID-19 vaccines for pregnant women after Kennedy said the shots would no longer be routinely recommended for that group. Doctors' groups also opposed Kennedy's changes to the vaccine committee. The new members he picked include a scientist who researched mRNA vaccine technology and became a conservative darling for his criticisms of COVID-19 vaccines, a top critic of pandemic-era lockdowns and a leader of a group that has been widely considered to be a source of vaccine misinformation. The American Academy of Pediatrics has long put out its own immunization recommendations. In recent decades it has matched what the government recommended. But asked if they might soon diverge, depending on potential changes in the government's vaccination recommendations, Kressly said; 'Nothing's off the table.' 'We will do whatever is necessary to make sure that every child in every community gets the vaccines that they deserve to stay healthy and safe,' she said. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Yahoo
4 hours ago
- Yahoo
'We are still here, yet invisible.' Study finds that U.S. government has overestimated Native American life expectancy
Official U.S. records dramatically underestimate mortality and life expectancy disparities for Native Americans, according to a new, groundbreaking study published in the Journal of the American Medical Association. The research, led by the Boston University School of Public Health, provides compelling evidence of a profound discrepancy between actual and officially reported statistics on the health outcomes of American Indian and Alaska Native (AI/AN) populations in the U.S. The study, novel in its approach, tracks mortality outcomes over time among self-identified AI/AN individuals in a nationally representative cohort known as the Mortality Disparities in American Communities. The researchers linked data from the U.S. Census Bureau's 2008 American Community Survey with official death certificates from the Centers for Disease Control and Prevention's National Vital Statistics System from 2008 through 2019, and found that the life expectancy of AI/AN populations was 6.5 years lower than the national average. They then compared this to data from the CDC's WONDER database, and found that their numbers were nearly three times greater than the gap reported by the CDC. Indeed, the study found that the life expectancy for AI/AN individuals was just 72.7 years, comparable to that of developing countries. The researchers also uncovered widespread racial misclassification. The study reports that some 41% of AI/AN deaths were incorrectly classified in the CDC WONDER database, predominantly misrecorded as 'White.' These systemic misclassifications drastically skewed official statistics, presenting AI/AN mortality rates as only 5% higher than the national average. When they adjusted the data to account for those misclassifications, the researchers found that the actual rate was 42% higher than initially reported. The issue of racial misclassification 'is not new for us at all,' said Nanette Star, director of policy and planning at the California Consortium for Urban Indian Health. The recent tendency for journalists and politicians to use umbrella terms like 'Indigenous' rather than the more precise 'American Indian and Alaska Native' can obscure the unique needs, histories and political identities of AI/AN communities, Star noted, and contribute to their erasure in both data and public discourse. 'That is the word we use — erasure — and it really does result in that invisibility in our health statistics,' she said. Issues related to racial misclassification in public records persist across the entire life course for AI/AN individuals, from birth to early childhood interventions to chronic disease and death. Star noted that in California, especially in urban regions like Los Angeles, Native individuals are frequently misidentified as Latino or multiracial, which profoundly distorts public health data and masks the extent of health disparities. 'It really does mask the true scale of premature mortality and health disparities among our communities,' Star said. Further, said Star, the lack of accurate data exacerbates health disparities. 'It really is a public health and justice issue,' she said. 'If you don't have those numbers to support the targeted response, you don't get the funding for these interventions or even preventative measures.' According to U.S. Census data, California is home to the largest AI/AN population in the United States. That means it has a unique opportunity to lead the nation in addressing these systemic issues. With numerous federally and state-recognized tribes, as well as substantial urban AI/AN populations, California can prioritize collaborative and accurate public health data collection and reporting. Star noted that current distortions are not always malicious but often stem from a lack of training. She suggested that California implement targeted training programs for those charged with recording this data, including funeral directors, coroners, medical doctors and law enforcement agents; allocate dedicated resources to improve the accuracy of racial classification on vital records; and strengthen partnerships with tribal leaders. The study authors suggest similar approaches, and there are numerous examples of successful cases of Indigenous-led health partnerships seen across Canada and the U.S. that have helped reduce health disparities among AI/AN communities that could be used as a template. These efforts would not only help to move toward rectifying historical inaccuracies, but also ensure that AI/AN communities receive equitable health resources and policy attention. 'When AI/AN people are misclassified in life and in death, it distorts public health data and drives inequities even deeper,' said Star. 'Accurate data isn't just about numbers — it's about honoring lives, holding systems accountable and making sure our communities are seen and served.' This story originally appeared in Los Angeles Times.
Los Angeles Times
4 hours ago
- Los Angeles Times
‘We are still here, yet invisible.' Study finds that U.S. government has overestimated Native American life expectancy
Official U.S. records dramatically underestimate mortality and life expectancy disparities for Native Americans, according to a new, groundbreaking study published in the Journal of the American Medical Association. The research, led by the Boston University School of Public Health, provides compelling evidence of a profound discrepancy between actual and officially reported statistics on the health outcomes of American Indian and Alaska Native (AI/AN) populations in the U.S. The study, novel in its approach, tracks mortality outcomes over time among self-identified AI/AN individuals in a nationally representative cohort known as the Mortality Disparities in American Communities. The researchers linked data from the U.S. Census Bureau's 2008 American Community Survey with official death certificates from the Centers for Disease Control and Prevention's National Vital Statistics System from 2008 through 2019, and found that the life expectancy of AI/AN populations was 6.5 years lower than the national average. They then compared this to data from the CDC's WONDER database, and found that their numbers were nearly three times greater than the gap reported by the CDC. Indeed, the study found that the life expectancy for AI/AN individuals was just 72.7 years, comparable to that of developing countries. The researchers also uncovered widespread racial misclassification. The study reports that some 41% of AI/AN deaths were incorrectly classified in the CDC WONDER database, predominantly misrecorded as 'White.' These systemic misclassifications drastically skewed official statistics, presenting AI/AN mortality rates as only 5% higher than the national average. When they adjusted the data to account for those misclassifications, the researchers found that the actual rate was 42% higher than initially reported. The issue of racial misclassification 'is not new for us at all,' said Nanette Star, director of policy and planning at the California Consortium for Urban Indian Health. The recent tendency for journalists and politicians to use umbrella terms like 'Indigenous' rather than the more precise 'American Indian and Alaska Native' can obscure the unique needs, histories and political identities of AI/AN communities, Star noted, and contribute to their erasure in both data and public discourse. 'That is the word we use — erasure — and it really does result in that invisibility in our health statistics,' she said. Issues related to racial misclassification in public records persist across the entire life course for AI/AN individuals, from birth to early childhood interventions to chronic disease and death. Star noted that in California, especially in urban regions like Los Angeles, Native individuals are frequently misidentified as Latino or multiracial, which profoundly distorts public health data and masks the extent of health disparities. 'It really does mask the true scale of premature mortality and health disparities among our communities,' Star said. Further, said Star, the lack of accurate data exacerbates health disparities. 'It really is a public health and justice issue,' she said. 'If you don't have those numbers to support the targeted response, you don't get the funding for these interventions or even preventative measures.' According to U.S. Census data, California is home to the largest AI/AN population in the United States. That means it has a unique opportunity to lead the nation in addressing these systemic issues. With numerous federally and state-recognized tribes, as well as substantial urban AI/AN populations, California can prioritize collaborative and accurate public health data collection and reporting. Star noted that current distortions are not always malicious but often stem from a lack of training. She suggested that California implement targeted training programs for those charged with recording this data, including funeral directors, coroners, medical doctors and law enforcement agents; allocate dedicated resources to improve the accuracy of racial classification on vital records; and strengthen partnerships with tribal leaders. The study authors suggest similar approaches, and there are numerous examples of successful cases of Indigenous-led health partnerships seen across Canada and the U.S. that have helped reduce health disparities among AI/AN communities that could be used as a template. These efforts would not only help to move toward rectifying historical inaccuracies, but also ensure that AI/AN communities receive equitable health resources and policy attention. 'When AI/AN people are misclassified in life and in death, it distorts public health data and drives inequities even deeper,' said Star. 'Accurate data isn't just about numbers — it's about honoring lives, holding systems accountable and making sure our communities are seen and served.'
